Clinical Trial Update: Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update for tandospirone citrate in generalized anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Tandospirone citrate (tandospirone citrate)

Snippet

Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED